Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells.
about
Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligandEvaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemiaExploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell VaccinesAntitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentationDendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytesMechanisms of action of therapeutic antibodies for cancerAn efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinomaPhase I dendritic cell p53 peptide vaccine for head and neck cancer.Regulation of HSP70 on activating macrophages using PDT-induced apoptotic cells.Hyperthermia as an immunotherapy strategy for cancerPoly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DCHuman tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo.Monoclonal antibodies: versatile platforms for cancer immunotherapy.Immunotherapeutic Intervention against Sarcomas.Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells.Amino acid residues in the carboxy-terminal region of cottontail rabbit papillomavirus E6 influence spontaneous regression of cutaneous papillomas.Membrane repair and immunological danger.Immune complex-mediated antigen presentation induces tumor immunity.Whole tumor antigen vaccines.Anti-CD3/anti-epidermal growth factor receptor-bispecific antibody retargeting of lymphocytes against human neoplastic keratinocytes in an autologous organotypic culture model.Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function.Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells.Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells.Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy.Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.Cancer vaccine by fusions of dendritic and cancer cells.The future of glioblastoma therapy: synergism of standard of care and immunotherapy.Identification of pancreatic cancer-associated tumor antigen from HSP-enriched tumor lysate-pulsed human dendritic cells.Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking.Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.Activated apoptotic cells induce dendritic cell maturation via engagement of Toll-like receptor 4 (TLR4), dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN), and β2 integrins.
P2860
Q24683245-14700DD1-50E3-48F8-89EA-BC1BAFEB6328Q24800882-DA13852F-5A83-4BD1-9061-C6CA683D7D80Q26772715-845C0C6F-A2B7-488D-BD7D-682B8C7704EFQ27026193-B95E261F-3C51-44F4-B92C-B5B447789692Q27310806-30D23FFC-F278-4C04-8B7B-4EE8E6007C60Q28385366-0BED8D6B-EF71-46A9-8C5B-4560AE548610Q28749871-72E13030-209D-458B-861A-87A60D64C363Q30577847-B7521CE6-8348-4146-BE3A-98947631C051Q33469738-6789C3A5-4522-4FEB-8005-BF47BD035D82Q33686985-EF649D36-9582-48B7-82FD-3EAA878821DFQ33940675-94796EBD-D226-4691-B26D-62BDBD50C56AQ34035529-5A2FA972-F77B-4F0B-9EA1-F878227940E0Q34111693-AE9EE305-3C7A-4D80-8BF2-11C48584D18FQ34196481-93C07BCB-AF9B-4EFF-B490-82996D6930A6Q34332462-AF45548F-18ED-4B9D-82CC-CDB5FB9F4869Q34359718-546FBD31-66C3-422D-9FA1-6CE2245441F6Q34360555-737A3B08-E760-4D9F-BB63-E0883011E889Q34793164-270C2CB9-420E-4860-ACAE-409FBD3CF9B8Q35058235-10E869A4-0DB9-44CF-A9EA-6AE75E761C19Q35750258-C1B5B233-167C-4A7B-87E3-8625C7CB4AE6Q35848688-FEC8D848-02C0-4691-B077-003FA9C59641Q35849871-5C8A38E5-24BD-4445-8EAF-7AE3E1255297Q36376481-901CFBC3-58DA-4305-8A1A-00CB7E1E2C57Q36691357-F21D931E-3C46-4473-B774-3E7EEEB649C8Q37513293-8C926267-F4CE-40AC-B910-56E0B0042BF9Q37676077-757478F3-0585-459E-8F4A-A4BFB27E961DQ37698219-C45DB049-E528-4813-99EE-CF9F4812E4DFQ38255481-AAD2CF31-889B-4F91-9D87-6014B7FBDF56Q38437145-FF5EAEA6-6A18-47F5-8A27-FF8D248F66D1Q39912198-BAD609CB-8A0C-4672-B097-2624BE107021Q41237376-25201801-1C58-4A05-A939-95E3A35CD3D8Q41869877-AB97E1BD-C911-4A57-BFC4-500511FE67B3
P2860
Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Generation of tumor-specific T ...... gesting apoptotic tumor cells.
@en
type
label
Generation of tumor-specific T ...... gesting apoptotic tumor cells.
@en
prefLabel
Generation of tumor-specific T ...... gesting apoptotic tumor cells.
@en
P2093
P1433
P1476
Generation of tumor-specific T ...... gesting apoptotic tumor cells.
@en
P2093
Dworacki G
Hoffmann TK
Meidenbauer N
Whiteside TL
P304
P407
P577
2000-07-01T00:00:00Z